AstraZeneca Q4 Earnings Beat, Sales Hurt By COVID Jab
February 09, 2023 at 08:23 AM EST
Core earnings of $1.38 per share declined 17% year over year on a reported basis and 5% at constant exchange rates (CER).
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Calendar | Directory | Real Estate | Blog | More
|